The Journal of Affective Disorders is a premier publication in the field of Clinical Psychology and Psychiatry and Mental Health, published by Elsevier. With an impressive impact factor and a consistent ranking in the Q1 category—12th in Clinical Psychology and 40th in Psychiatry and Mental Health—the journal serves as a critical platform for advancing research on affective disorders since its inception in 1979. The journal’s scope encompasses a wide range of topics related to mood disorders, providing researchers, professionals, and students with the latest findings, theoretical developments, and clinical insights. Despite being a non-open-access journal, subscribers benefit from comprehensive access to high-quality, peer-reviewed articles that inform clinical practice and enrich academic discourse. With its commitment to fostering scientific progress, The Journal of Affective Disorders remains instrumental in shaping the future of mental health research and practice.

BioPsychoSocial Medicine is a pioneering open-access journal published by BMC that has been at the forefront of integrating biological, psychological, and social perspectives in medicine since its inception in 2007. With a commitment to advancing research in the fields of biological psychiatry, psychology, and mental health, this journal has solidified its reputation, achieving notable ranking quartiles including Q2 in both Psychiatry and Mental Health, as well as Psychology categories as of 2023. Researchers and professionals can explore a wealth of interdisciplinary studies that bridge the gaps across these fields, facilitating a comprehensive understanding of mental health issues. As a vital resource for the academic community, BioPsychoSocial Medicine promotes innovative research that not only sheds light on complex psychological phenomena but also informs clinical practices and policies. The journal, indexed in Scopus, encourages knowledge sharing and collaboration, making it an indispensable platform for students, researchers, and practitioners alike in their pursuit of excellence in psychosocial medicine.

Psychoterapia, published by the Polish Psychiatric Association, is an esteemed academic journal dedicated to the fields of clinical psychology and psychiatry. Established in 2001 and continuing its publication until 2023, this journal serves as a significant platform for the dissemination of research, clinical practices, and theoretical advancements in the realm of mental health. Although it currently holds a Q4 ranking in both the Clinical Psychology and Psychiatry and Mental Health categories, it is committed to improving the understanding and treatment of psychological disorders through rigorous peer-reviewed articles. With its ISSN 0239-4170 and E-ISSN 2391-5862, Psychoterapia provides vital insights that are of interest to researchers, clinicians, and students alike. While the journal does not offer open access options, it remains a recommended resource to further stimulate research and dialogue in the field of psychotherapy.

Welcome to the British Journal of Clinical Psychology, a leading publication in the field of psychology, particularly recognized for its contributions to clinical practice and research since its inception. Published by Wiley, the journal boasts an impressive impact with a Q1 ranking in both Clinical Psychology and Medicine (Miscellaneous) categories as of 2023, evidenced by its placement at rank #65 out of 311 in Scopus for Clinical Psychology, reflecting its impactful and high-quality contributions in the domain. With a history stretching back to 1962 and ongoing publication through 2024, the journal provides a rigorous platform for researchers, professionals, and students to disseminate and engage with innovative studies, methodologies, and clinical insights. Although it does not currently operate under an Open Access model, the journal’s commitment to enhancing knowledge and practice in clinical psychology makes it an indispensable resource for anyone involved in psychological research and practice.

Trends in Psychiatry and Psychotherapy, published by ASSOC PSIQUIATRIA RIO GRANDE SUL, is a leading open-access journal dedicated to advancing the fields of psychiatry and mental health. Since its inception in 2011, this Brazilian journal has committed itself to disseminating high-quality research and innovative clinical practices, providing a platform for both established researchers and emerging voices in the field. With a notable impact factor and ranking within the Q2 quartile for both psychiatry and miscellaneous medicine categories in 2023, this journal is recognized for its significant contribution to the academic community. It serves as a vital resource for researchers, professionals, and students alike, facilitating knowledge exchange and fostering collaboration across disciplines. The open-access model ensures that cutting-edge findings are accessible to a global audience, enhancing the discourse surrounding mental health and psychiatric care. For more information and to explore current publications, please visit the journal's website.

Journal of Experimental Psychopathology, published by SAGE Publications Ltd, stands as a pivotal platform for advancing the understanding of psychological disorders and their underlying mechanisms. Established in 2015, this open access journal encourages a broad dissemination of research findings, adhering to its mission to foster innovation in the fields of Clinical Psychology and Psychiatry and Mental Health. With an established impact recognized in its Q3 quartile rankings for both fields as of 2023, the journal aims to bridge the gap between experimental research and clinical application. Researchers, professionals, and students are invited to engage with cutting-edge studies, all while benefiting from the journal's commitment to open access publishing since 2018, ensuring that knowledge is easily accessible to all. The journal’s office is strategically located in London, UK, serving a global academic community keen on exploring the complexities of psychopathology.

The Scandinavian Journal of Child and Adolescent Psychiatry and Psychology is a premier platform for disseminating significant research in the fields of child and adolescent mental health. Published by SCIENDO, this journal has embraced an Open Access model since 2013, promoting wider accessibility to vital findings and discussions in this pivotal area of study. With a unique focus on issues facing young individuals, it aims to bridge gaps between research, clinical practice, and policy-making. The journal invites submissions from researchers, clinicians, and practitioners worldwide, ensuring a diverse range of perspectives and contributions. By fostering scholarly dialogue and innovation, it plays an essential role in advancing knowledge and improving outcomes in child and adolescent psychiatry and psychology, making it a crucial resource for anyone invested in the mental well-being of young populations.

The BULLETIN OF THE MENNINGER CLINIC, an esteemed publication of GUILFORD PUBLICATIONS INC, has been a pivotal resource in the fields of Clinical Psychology and Psychiatry since its inception in 1945. With ISSN 0025-9284 and E-ISSN 1943-2828, this journal is recognized for its commitment to advancing knowledge and practices in mental health. Indexed in Scopus with respectable rankings across various categories, it stands in the Q3 quartile for both Clinical Psychology and Psychiatry and Mental Health, indicating its role as a significant contributor to academic discourse. Although it operates under a subscription model, the journal features a broad spectrum of peer-reviewed articles, case studies, and research findings that are essential for professionals, researchers, and students dedicated to understanding and improving mental health care. The BULLETIN OF THE MENNINGER CLINIC serves as a vital platform for interdisciplinary dialogue, fostering innovative approaches and methodologies that shape the future of mental health treatment and research.

CHILD PSYCHIATRY & HUMAN DEVELOPMENT, published by Springer, stands at the forefront of research in the fields of developmental and educational psychology, pediatrics, perinatology, and child psychiatry. With an ISSN of 0009-398X and an E-ISSN of 1573-3327, this esteemed journal has been a vital resource for academics since its inception in 1970. Currently ranked in the Q1 category across its multiple relevant disciplines, it illustrates a significant impact with its Scopus rankings, placing it within the top 13% for pediatrics and child health and the top 18% for developmental psychology. Its comprehensive scope ensures that leading-edge studies, reviews, and discourse are accessible, contributing greatly to the understanding of mental health and developmental processes in children. With no open access option, the journal maintains a commitment to high-quality, peer-reviewed content that is invaluable for researchers, healthcare professionals, and students alike, as they strive to advance their knowledge and practices in child psychology and human development.

Neuropsychopharmacology Reports is a leading open-access journal published by WILEY, dedicated to advancing the fields of clinical psychology, pharmacology, psychiatry, and mental health. Established in 2018, the journal aims to disseminate high-quality research findings, critical reviews, and innovative methodologies that elucidate the complexities of neuropsychopharmacology in enhancing mental health outcomes. With an impressive impact indicated by its Q2 rankings in several categories including Clinical Psychology and Pharmacology (medical) as of 2023, Neuropsychopharmacology Reports stands out as a vital resource for researchers, professionals, and students keen on exploring the interplay between pharmacological interventions and psychological well-being. The journal’s open-access nature ensures that critical advancements in this rapidly evolving field are readily available to a global audience, fostering collaboration and discourse among scholars and practitioners alike. Building on its indexed status with Scopus, the journal is positioned as a noteworthy contributor to ongoing discussions and developments in psychiatry and medical pharmacology.